
SLS Technical Analysis Summary (NASDAQ)
Analyze SLS on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerSLS Technical Analysis Summary (NASDAQ)
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) stock currently shows a bullish trend on the NASDAQ, supported by momentum and strong buying pressure.
Technical conditions suggest SELLAS Life Sciences Group, Inc. on the NASDAQ is awaiting a decisive move. Technical conditions suggest SELLAS Life Sciences Group, Inc. is consolidating, awaiting a decisive move.
RSI (14): 58.46
Stochastic %K: 77.28
Williams %R: -36.00
Rate of Change (ROC): 17.50
Takeaway:SELLAS Life Sciences Group, Inc. shows strong bullish momentum, with buyers firmly in control.
MACD: 0.74
ADX: 32.39
ATR (14): 1.24
CCI (14): 103.28
Takeaway:SELLAS Life Sciences Group, Inc. shows a firm trend supported by momentum, though one signal suggests caution.
Takeaway:SELLAS Life Sciences Group, Inc. trades closer to resistance, supported by stronger momentum within bands.
Takeaway:SELLAS Life Sciences Group, Inc. trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:SLS shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
No significant bearish signals detected.
Overall Recommendation:Technical indicators for SELLAS Life Sciences Group, Inc. are mixed, suggesting a Hold or wait-and-see approach.